Grimes & Company’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $4.84K | Sell |
|
|||||
|
2024
Q4 | $21.4K | Hold |
|
|||||
|
2024
Q3 | $28.3K | Hold |
|
|||||
|
2024
Q2 | $30.1K | Sell |
|
|||||
|
2024
Q1 | $68.8K | Sell |
|
|||||
|
2023
Q4 | $36.3K | Sell |
|
|||||
|
2023
Q3 | $20.5K | Buy |
|
|||||
|
2023
Q2 | $51.8K | Buy |
|
|||||
|
2023
Q1 | $64.1K | Buy |
|
|||||
|
2022
Q4 | $89.5K | Buy |
|
|||||
|
2022
Q3 | $103K | Buy |
|
|||||
|
2022
Q2 | $69K | Buy |
|
|||||
|
2022
Q1 | $57K | Buy |
|